Cargando…
Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies
The prosocial neuropeptide oxytocin is being developed as a potential treatment for various neuropsychiatric disorders including autism spectrum disorder (ASD). Early studies using intranasal oxytocin in patients with ASD yielded encouraging results and for some time, scientists and affected familie...
Autores principales: | Althammer, Ferdinand, Muscatelli, Francoise, Grinevich, Valery, Schaaf, Christian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360032/ https://www.ncbi.nlm.nih.gov/pubmed/35941105 http://dx.doi.org/10.1038/s41398-022-02054-1 |
Ejemplares similares
-
Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene
por: Fountain, Michael D., et al.
Publicado: (2016) -
Schaaf-Yang syndrome shows a Prader-Willi syndrome-like phenotype during infancy
por: Negishi, Yutaka, et al.
Publicado: (2019) -
Hormonal Imbalances in Prader–Willi and Schaaf–Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals
por: Hoyos Sanchez, Maria Camila, et al.
Publicado: (2023) -
The adult phenotype of Schaaf-Yang syndrome
por: Marbach, Felix, et al.
Publicado: (2020) -
Natural breaking of the maternal silence at the mouse and human imprinted Prader-Willi locus: A whisper with functional consequences
por: Matarazzo, Valery, et al.
Publicado: (2013)